Diagnostics
U.S. MicroRNA Market to Reach $98.6 Million in 2015, Estimates Frost & Sullivan
Published in Health Business Week, May 22nd, 2009
Despite growing competition from new entrants, microRNA tool providers are witnessing extraordinary growth in their research product portfolios. As evidence of the link between microRNAs and disease grows, the diagnostic and therapeutic potential of these molecules will remain the driving forces behind market expansion. MicroRNA research offers the capability of moving from bench to bedside faster than most research fields, as diagnostic tests have already emerged from this young field.
New analysis from Frost & Sullivan U.S. MicroRNA Markets, finds that the market earned revenues of over $20.3 million in 2008 and estimates this to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-05-22)
More Articles from Health Business Week
- 1-800-FLOWERS.COM, Inc.
Send Mom Sweet Gifts from Cheryl&Co. - 104 West Partners
104 West Partners Awarded Three Hermes Creative Awards for Outstanding Public Relations Campaigns - 3M
3M Infection Prevention Division Launches New Sales Organization Representation for U.S. Physician Market - 3SBio Inc.
3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor - A Schmahl Science Workshop
A Schmahl Science Workshop Brings Free H1N1 Swine Flu-Prevention Workshops and Volunteer Training to Silicon Valley Schools - A.M. Best Co.
A.M. Best Special Report: U.S. Health—2008 GAAP Financial Review - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
